Home › Funds › Frazier Life Sciences Management, L.P. › GLUE

Frazier Life Sciences Management, L.P. position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 1,000,000 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$24.2M, representing 0.53% of its reported portfolio and ranking #32 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed GLUE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.00M sh
Reported value held$24.20M
Portfolio Weight0.53%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s GLUE position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in GLUE in Q1 2026 at 1,000,000 shares (US$16.4M). The position peaked in Q2 2026 at 1,000,000 shares, worth US$24.2M. Across 2 filings, Frazier Life Sciences Management, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,000,000 shares valued at US$24.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.00M $16.45M New
Q2 2026 1.00M $24.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held GLUE?

Frazier Life Sciences Management, L.P. has disclosed GLUE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Frazier Life Sciences Management, L.P.'s current position in GLUE?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 1.00M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $24.20M, representing 0.53% of its reported portfolio and ranking #32.

Has Frazier Life Sciences Management, L.P. been buying or selling GLUE?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in GLUE. The position peaked in Q2 2026 at 1.00M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.